|
|
|
|
| LEADER |
05342cam a22005897i 4500 |
| 001 |
MUB03000005210 |
| 003 |
CZ BrMU |
| 005 |
20230405072244.0 |
| 008 |
180803t20172017io |||||o|||||||||||eng d |
| STA |
|
|
|a EIZ
|b 333
|c EBSCO trvale nakupy
|d 2018-07-31
|
| 020 |
|
|
|a 978-981-10-0839-9
|q (eBook)
|
| 035 |
|
|
|a (OCoLC)ocn962154564
|
| 035 |
|
|
|a (OCoLC)962154564
|z (OCoLC)961910167
|z (OCoLC)962017240
|
| 040 |
|
|
|a EBLCP
|b cze
|e rda
|c EBLCP
|d N$T
|d YDX
|d GW5XE
|d N$T
|d OCLCQ
|d IDEBK
|d OCLCF
|d UAB
|d IOG
|d ESU
|d JBG
|d IAD
|d ICW
|d ICN
|d OTZ
|d OCLCQ
|d U3W
|d CAUOI
|d OCLCQ
|d BOD034
|
| 072 |
|
7 |
|a 616
|x Patologie. Klinická medicína
|2 Konspekt
|9 14
|
| 080 |
|
|
|a 616.24-007/-008
|2 MRF
|
| 080 |
|
|
|a 616.24
|2 MRF
|
| 245 |
0 |
0 |
|a Chronic obstructive pulmonary disease :
|b a systemic inflammatory disease /
|c Hiroyuki Nakamura, Kazutetsu Aoshiba, editors
|
| 264 |
|
1 |
|a Singapore :
|b Springer,
|c [2017]
|
| 264 |
|
4 |
|c ©2017
|
| 300 |
|
|
|a 1 online zdroj (xi, 351 stran) :
|b ilustrace
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a počítač
|b c
|2 rdamedia
|
| 338 |
|
|
|a online zdroj
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Respiratory Disease Series,
|x 2509-5552
|
| 505 |
0 |
|
|a Preface; References; Contents; Part I: Definition and Epidemiology; Chapter 1: Definition of Chronic Obstructive Pulmonary Disease (COPD): Is the Latest GOLD Classification of Severity Still Val ... ; 1.1 Introduction; 1.2 Historical Transition of the Concept of COPD; 1.3 Difference Between COPD and Bronchial Asthma; 1.4 Chronic Bronchitis and Pulmonary Emphysema; 1.5 Global Initiative for Chronic Obstructive Lung Disease (GOLD); 1.6 Combined COPD Assessment; 1.7 Conclusion; References; Chapter 2: Epidemiology of COPD: Why Is the Disease So Poorly Recognized?; 2.1 Introduction.
|
| 505 |
8 |
|
|a 2.2 Risk Factors of COPD2.2.1 Cigarette Smoking; 2.2.2 Other Risk Factors; 2.2.2.1 Genetic Factors; 2.2.2.2 Environmental Factors; Occupational Airborne Particles; Air Pollution; Indoor Air Pollutants; Outdoor Air Pollution; 2.2.2.3 Low Socioeconomic Status; 2.3 Decline in FEV1 in Patients with COPD; 2.4 Incidence of COPD; 2.5 Prevalence of COPD; 2.6 Undiagnosed COPD; 2.7 Impact of COPD on Health Status in the General Population; 2.8 Conclusions; References; Part II: Genetic Predisposition and Pathogenic Mechanisms.
|
| 505 |
8 |
|
|a Chapter 3: Genetic Predisposition to COPD: Are There Any Relevant Genes Determining the Susceptibility to Smoking?3.1 Introduction; 3.2 Investigation of the Genes Related to COPD Pathogenesis: The Era Before GWAS; 3.3 Genome-Wide Association Studies (GWASs) for Susceptibility Genes of COPD; 3.4 Recent Progress of Studies of COPD Genetics in GWAS Era (I): Relevant Genes Determining the Susceptibility to Smoking; 3.5 Recent Progress of Studies of COPD Genetics in GWAS Era (II): Gene Related to Critical Subtypes or Phenotypes of COPD.
|
| 505 |
8 |
|
|a 3.6 Recent Progress of Studies of COPD Genetics in GWAS Era (III): Novel Strategy for Research on COPD Genetics with Multi-omi ... 3.7 Recent Progress of Studies of COPD Genetics in GWAS Era (IV): Next-Generation Sequencing and Arrays; 3.8 Recent Progress of Studies of COPD Genetics in GWAS Era (V): Pharmacogenetics and Pharmacogenomics in COPD; 3.9 Conclusions; References; Chapter 4: Pathogenesis of COPD (Persistence of Airway Inflammation): Why Does Airway Inflammation Persist After Cessation of ... ; 4.1 Introduction; 4.2 Airway Inflammation and Changes in COPD.
|
| 505 |
8 |
|
|a 4.2.1 Airway Structure and Mucus Production in Patients with COPD4.2.2 Lung Destruction in COPD; 4.2.3 Inflammatory Cells and Cytokines in the Airway in COPD; 4.3 Airway Inflammation After Smoking Cessation; 4.3.1 Innate Immune System; 4.3.1.1 The Role of TLRs; 4.3.1.2 The Role of NLRs; 4.3.1.3 The Role of RLRs; 4.3.1.4 The Role of RAGE; 4.3.2 Adaptive Immune System; 4.3.2.1 The Role of B Cells; 4.3.2.2 The Role of T Cells; 4.3.3 COPD Deterioration After Smoking Cessation; 4.3.3.1 COPD Deterioration by COPD Itself; 4.3.3.2 COPD Deterioration by Latent Respiratory Infection.
|
| 533 |
|
|
|a Elektronická reprodukce.
|n Přístup pouze pro oprávněné uživatele
|
| 650 |
0 |
7 |
|a plicní nemoci
|2 czmesh
|
| 650 |
0 |
7 |
|a chronická obstrukční plicní nemoc
|2 czmesh
|
| 650 |
0 |
2 |
|a Lung Diseases
|
| 650 |
0 |
2 |
|a Pulmonary Disease, Chronic Obstructive
|
| 655 |
|
7 |
|a e-knihy online
|2 CZ-BrMU
|
| 655 |
|
9 |
|a e-books online
|2 eCZ-BrMU
|
| 700 |
1 |
|
|a Nakamura, Hiroyuki
|4 edt
|
| 700 |
1 |
|
|a Aoshiba, Kazutetsu
|4 edt
|
| 776 |
0 |
8 |
|i Tištěná verze:
|t Chronic obstructive pulmonary disease : a systemic inflammatory disease.
|z 978-981-10-0838-2
|
| 830 |
|
0 |
|a Respiratory disease series,
|x 2509-5552
|
| 856 |
4 |
1 |
|z Elektronická verze přístupná pouze pro studenty a pracovníky MU
|u https://ezproxy.muni.cz/login?url=https://search.ebscohost.com/login.aspx?authtype=ip&custid=s8431878&lang=cs&profile=eds&direct=true&db=nlebk&AN=1282162
|
| CAT |
|
|
|c 20180803
|l MUB03
|h 1520
|
| CAT |
|
|
|c 20190222
|l MUB03
|h 1623
|
| CAT |
|
|
|c 20190222
|l MUB03
|h 1659
|
| CAT |
|
|
|c 20210421
|l MUB03
|h 2124
|
| CAT |
|
|
|c 20210421
|l MUB03
|h 2208
|
| CAT |
|
|
|a VARTECKA
|b 02
|c 20230405
|l MUB03
|h 0722
|
| 995 |
|
|
|a eBook
|
| 994 |
- |
1 |
|l MUB03
|l MUB03
|m EBOOK
|1 KUK
|a Knihovna univ. kampusu
|2 VV
|b KUK - volný výběr
|5 3284L00488
|8 20180801
|f 83
|f Dálkově přístupná
|s kup
|
| AVA |
|
|
|a MED50
|b KUK
|c KUK - volný výběr
|e available
|t K dispozici
|f 1
|g 0
|h N
|i 0
|j VV
|
